Variation of activated partial thromboplastin time according to age and sex in a large population study: Analytical and clinical implications

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 2, 2012, Pages 177-178

  Lippi, Giuseppe ^a   Meschi, Tiziana ^a   Borghi, Loris ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; PHOSPHOLIPID; SILICON DIOXIDE;

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CLINICAL ASSESSMENT; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PARTIAL THROMBOPLASTIN TIME; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84856619169     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834ee0fb     Document Type: Letter

References (11)

1. Lippi G, Favaloro EJ. Activated partial thromboplastin time: new tricks for an old dogma. Semin Thromb Hemost 2008; 34:604-611.
2. Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis 2010; 21:459-463.
3. Mina A, Favaloro EJ, Mohammed S, Koutts J. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagul Fibrinolysis 2010; 21:152-157.
4. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104:3631-3634. (Pubitemid 39564438)
5. Ts'ao C, Neofotistos D, Oropeza M, Rogan M, Santos M. Performance characteristics of a new synthetic APTT reagent. Clin Lab Haematol 1998; 20:307-313. (Pubitemid 28480208)
6. Sánchez-Luceros A, Meschengieser SS, Marchese C, Votta R, Casais P, Woods AI, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis 2003; 14:647-651. (Pubitemid 37323742)
7. Luxembourg B, Schmitt J, Humpich M, Glowatzki M, Seifried E, LindhoffLast E. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels. Blood Coagul Fibrinolysis 2009; 20:524-534.
8. Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, Favaloro EJ. Epidemiological association between fasting plasma glucose and shortened APTT. Clin Biochem 2009; 42:118-120.
9. Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, Favaloro EJ. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis 2009; 28:362-365.
10. Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34:747-761.
11. ten Boekel E, de Kieviet W, Bartels PC. Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels. Scand J Clin Lab Invest 2003;63: 441-448. (Pubitemid 37303929)